long acting Injection [Design Issues]

posted by jag009  – NJ, 2020-04-21 23:06 (1407 d 13:22 ago) – Posting: # 21342
Views: 1,489

Hi,

❝ But if it is mentioned in monograph that half-life is 17 days following single dose and 46 days after multiple dose, then which half-life we should consider while designing multiple dose study? In the same monograph, it is also stated that steady state is achieved after 4th dose on injection.


Have you found out why the increase in half-life?

J

Complete thread:

UA Flag
Activity
 Admin contact
22,912 posts in 4,806 threads, 1,637 registered users;
31 visitors (0 registered, 31 guests [including 6 identified bots]).
Forum time: 11:28 CET (Europe/Vienna)

Exploratory analysis: The art of finding a Rembrandt
in a Jackson Pollock.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5